Cite
PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia.
MLA
Lima, Keli, et al. “PIP4K2A and PIP4K2C Transcript Levels Are Associated with Cytogenetic Risk and Survival Outcomes in Acute Myeloid Leukemia.” Cancer Genetics, vol. 233, Apr. 2019, pp. 56–66. EBSCOhost, https://doi.org/10.1016/j.cancergen.2019.04.002.
APA
Lima, K., Coelho-Silva, J. L., Kinker, G. S., Pereira-Martins, D. A., Traina, F., Fernandes, P. A. C. M., Markus, R. P., Lucena-Araujo, A. R., & Machado-Neto, J. A. (2019). PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia. Cancer Genetics, 233, 56–66. https://doi.org/10.1016/j.cancergen.2019.04.002
Chicago
Lima, Keli, Juan Luiz Coelho-Silva, Gabriela Sarti Kinker, Diego Antonio Pereira-Martins, Fabiola Traina, Pedro Augusto Carlos Magno Fernandes, Regina Pekelmann Markus, Antonio Roberto Lucena-Araujo, and João Agostinho Machado-Neto. 2019. “PIP4K2A and PIP4K2C Transcript Levels Are Associated with Cytogenetic Risk and Survival Outcomes in Acute Myeloid Leukemia.” Cancer Genetics 233 (April): 56–66. doi:10.1016/j.cancergen.2019.04.002.